St. Francis Hospital, New York
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, St. Francis Hospital, New York sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
St. Francis Hospital, New York: 5 sponsored US clinical trials, 2 recruiting.
St. Francis Hospital, New York sponsors 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Bypass Graft Stenosis, with 1 trials.
Upper-quartile sponsor footprint
St. Francis Hospital, New York sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
The STAND-UP Study
NCT07195903
Optical Coherence Tomography of the Saphenous Vein Graft
NCT05129228
Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting
NCT04621461
Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting
NCT04370782
The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)
NCT01078272
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 2 |
Therapeutic Areas
Where St. Francis Hospital, New York enrollment is open (later-stage tilt)
2 recruiting of 5 indexed (40% open); 2 completed (40%).
Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Coronary Bypass Graft Stenosis (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
St. Francis Hospital, New York: open-pipeline peers nationwide
Peers matched on 5 registered trials and 40% open enrollment, not the therapeutic-area sidebar.
St. Francis Hospital, New York sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 40% open enrollment (± trial volume)
- Ad scientiam · 40% recruiting · 5 trials
- Alto Neuroscience · 40% recruiting · 10 trials
- Bonafide Health · 40% recruiting · 5 trials
- Brooks Rehabilitation · 40% recruiting · 5 trials
Related
What to do with this St. Francis Hospital, New York page
5 registered trials is a research-attention snapshot, not an endorsement of St. Francis Hospital, New York or any single study.
- 2 of St. Francis Hospital, New York's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Bypass Graft Stenosis is the condition St. Francis Hospital, New York studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Bypass Graft Stenosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. St. Francis Hospital, New York pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.